Analytical Ultracentrifugation (AUC): A High-Precision Window into GLP1 Peptide Therapeutics

By Beckman Coulter On Jul 27, 2026

The Optima AUC instrument enables precise quantification of peptide species, providing valuable insight into sample purity. This capability supports applications such as: • Lot-release testing • Stability studies • Batch-to-batch comparisons.

Why downloads this whitepaper?

Analytical Development Head/Scientist – This case study provides a detailed workflow on Analytical Ultracentrifugation use case to solve one of the hardest problems in peptide therapeutics characterizing self-association, multimerization and aggregation analysis in it’s native state.

First Name (required)

Last Name (required)

Email (required)

Phone/Mobile Number (required)

Designation (required)

Company Name (required)

Company Address

City (required)

Yes, I subscribe to marketing communications from Beckman Coulter Life Sciences about its products, events and services.

By submitting this form, you are confirming you are an adult 18 years or older and agree to Express Pharma contacting you with marketing-related emails or by telephone. You may unsubscribe from receiving such communications from Express Pharma at any time. Express Pharma web sites and communications are subject to our Privacy Notice and Terms of Use.

Yes, I would like to receive email updates about Beckman Coulter products, services and events.
For full details of how we will treat your information please view our privacy policy: Privacy Notice and Terms of Use.

I would like to signup for Express Pharma Newsletter

I would like to signup for Express Pharma Newsletter